微信小陈
微信小章| 产品名称： | Aspergillus alliaceus Thom et Church, anamorph |
|---|---|
| 商品货号： | TS140633 |
| Strain Designations： | NRRL 315 4656, CBS 536.65, IFO 7538, IMI 51982, QM 1885, WB 315 |
| Alternate State： | Petromyces alliaceus Malloch et Cain, teleomorph |
| Application： | transformation of flavonoids |
| Biosafety Level： | 1
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Product Format： | freeze-dried |
| Type Strain： | no |
| Intended Use： | |
| Preceptrol®： | no |
| Comments： | with teleomorph |
| Medium： | ATCC® Medium 325: Malt extract agar (Blakeslees formula) |
| Growth Conditions： | Temperature: 24.0°C |
| Sequenced Data： | No DNA sequencing was performed in house on this product.
|
| Name of Depositor： | NRRL |
| Chain of Custody： | ATCC < |
| Isolation： | dead blister beetle, Macrobasis albida, Washington, DC |
| References： | Goetz MA, et al. Asperlicin, a novel non-peptidal cholecystokinin antagonist from Aspergillus alliaceus. Fermentation, isolation and biological properties. J. Antibiot. 38: 1633-1637, 1985. PubMed: 3005212 Ibrahim AR, Abul-Hajj YJ. Microbiological transformation of flavone and isoflavone. Xenobiotica 20: 363-373, 1990. PubMed: 2346033 Formisyn P, et al. Biotransformation by fungi: oxidation of ellipticine into 9-hydroxy-ellipticine by an Aspergillus alliaceus strain CBS 536.65. Lett. Appl. Microbiol. 19: 244-246, 1994. Laakso JA, et al. Isokotanins A-C: new bicoumarins from the sclerotia of Aspergillus alliaceus. J. Nat. Prod. 57: 128-133, 1994. PubMed: 8158157 Chien MM, Rosazza JP. Microbial transformations of natural antitumor agents. VIII. Formation of 8- and 9-hydroxy-ellipticines. Drug Metab. Dispos. 7: 211-214, 1979. PubMed: 39722 Burkhead KD, et al. I. Hydroxylation of aniline by Aspergillus alliaceus, A. albertensis and A. terreus. J. Ind. Microbiol. 13: 233-237, 1994. |